NASDAQ:SPRY | Key Financial Ratios | ARS Pharmaceuticals, Inc.

Complete source-backed ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-303.48-86.35%-1721.80%
2026-03-314.94-68.84%-322.92%
2025-12-317.28-52.28%-149.92%
2025-09-306.66-21.47%-54.21%
2025-06-306.17-15.32%-24.97%
2025-03-3111-4.78%-6.83%
2024-12-3114.262.28%3.11%
2024-09-3012.56-22.57%-24.43%
2024-06-3032.82-20.20%-20.83%
2024-03-3160.9-21.84%-22.20%
2023-12-3196.92-23.31%-23.56%
2023-09-3021.87-24.79%-25.97%
2023-06-3025.37-20.62%-21.46%
2023-03-3127.18-15.63%-16.23%
2022-12-3151.01-12.32%-12.71%
2022-09-3067.879.42%-50.89%
2022-06-3023.613.21%-21.46%
2022-03-3117.65-2.76%22.55%
2021-12-317.42-32.94%64.74%
2021-09-3019.9-22.44%-23.82%
2021-06-3023.35-17.59%-18.47%
2021-03-3132.63-12.18%-12.63%
2020-12-3140.69-8.35%234.46%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-317.28-52.28%-149.92%
2024-12-3114.262.28%3.11%
2023-12-3196.92-23.31%-23.56%
2022-12-3151.01-12.32%-12.71%
2021-12-317.42-32.94%64.74%
2020-12-3140.69-8.35%234.46%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.